Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RNA called metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to suppress breast cancer metastasis in mice, suggesting a potential new area of therapeutic investigation. The findings, published in the Oct. 22 online issue of Nature Genetics, were surprising given that MALAT1, a long non-coding RNA (lncRNA), previously was described as a metastasis promoter.
“Our six-year study unearthed the unexpected metastasis-suppressing function of MALAT1 through highly rigorous genetics approaches,” said Li Ma, Ph.D., associate professor of Experimental Radiation Oncology and principal investigator for the study. “Our findings defy the conclusions drawn from previous MALAT1 studies and suggest the potential value of therapeutic agents targeting a cellular pathway linked to MALAT1. However, this will require further clinical investigation.”
Halting a key protein behind metastasis
Ma’s team observed that MALAT1 sequestered and inactivated a protein known as TEAD, a transcription factor, which when combined with a “co-activator” called YAP, causes cancer proliferation and metastatic progression. The researchers discovered that MALAT1 binds and inactivates TEAD, preventing it from partnering with YAP and targeting genes in promoting metastasis.
Although MALAT1 had been associated with metastasis, the team, using a breast cancer transgenic mouse model, inactivated the MALAT1 gene without altering expression of its adjacent genes and observed that MALAT1 inactivation promoted lung metastasis, which was reversed when MALAT1 was re-introduced.
Similarly, knockout of MALAT1 in human breast cancer cells induced their metastatic ability, which was reversed by the re-introduction of MALAT1. Additionally, overexpression of MALAT1 suppressed breast cancer metastasis in several mouse models.
“Taken together, our study reveals the unexpected function of MALAT1 through comprehensive gene targeting and genetic rescue approaches in multiple in vivo models,” said Ma. “These findings call for a reassessment of ongoing efforts to target MALAT1 as an anti-metastatic therapeutic strategy, and provide a general framework for pursuing a better understanding of lncRNAs.”
RNA promotes metastasis in lung cancer
Long noncoding RNA MALAT1 suppresses breast cancer metastasis, Nature Genetics (2018). DOI: 10.1038/s41588-018-0252-3 , https://www.nature.com/articles/s41588-018-0252-3
February 17, 2019
February 17, 2019
- Sinks by Toilets in ICU Patient Rooms Harbor Harmful Bacteria
- Cancer cells’ plasticity makes them harder to stop
- Young cannabis users have increased risk of depression and suicidal behavior
- Tasmanian Devils Likely to Survive Cancer Scourge
- Neoadjuvant PD-1 blockade seems effective in glioblastoma
- Personal, social factors play role in enabling sustainable return to work after ill health
- Mouse studies show ‘inhibition’ theory of autism wrong
- Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins
- Use of liver grafts from older donors decreased despite better outcomes in recipients
- MUSC researchers discover new mechanism for a class of anti-cancer drugs
- HPV misconceptions are causing women to miss smear tests
- Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price
- Researchers say auditory testing can identify children for autism screening
- New method analyzes how single biological cells react to stressful situations
- WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers
- ADHD diagnoses poorly documented
- Majority of gender minority youth do not identify with traditional sexual identity labels
- AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma
- Lower Birth Weight May Up Risk for Psychiatric Disorders
- Scientists identify reversible molecular defect underlying rheumatoid arthritis